- 新聞
- 活動
- 文獻發表
- 外部來源
-
2025May
06
HCmed’s article on Smart Breath-Actuated Mesh Nebulisers is now featured in PMPS Inhalation Supplement 2025! 📰✨HCmed’s article on Smart Breath-Actuated Mesh Nebulisers is now featured in PMPS Inhalation Supplement 2025! 📰✨
-
2024Nov
13
Improving Aerosol Delivery: Nanosuspension and Mesh Technology🙌🏻Read HCmed’s latest publication in Pulmonary and Nasal Drug Delivery, Issue No 167, of ONdrugDelivery
-
2023Dec
13
Customisable Nebuliser Platform to Monitor AdheRenceThe HCmed's team describes the value that customisable nebuliser platforms bring to patient adherence
-
2023Dec
06
Assessment of Aerosol Characterisation and Delivery Performance of a Solution Using Different Configurations of a Breath-Actuated Mesh NebuliserThe overall scope of the study presents the benefits of an exploratory work at the development stage of a new drug-nebuliser combination product, aiming to identify the most suitable pair for the targeted delivery requirements.
-
2023Nov
13
The Value of Customisable Mesh Nebuliser Platforms in Combination Product DevelopmentThe HCmed's team looks at the advantages of customisable nebuliser platforms for new combination products
-
2023Feb
23
Stability and Activity of Interferon Beta to Treat Idiopathic Pulmonary Fibrosis with Different Nebulizer TechnologiesThe investigations revealed the potential efficacy of IFN-β in the treatment of IPF with the mesh nebulizer, demonstrating the higher efficiency of IFN-β delivered through the mesh nebulizer.
-
2022Dec
13
Advancements in Monitoring Adherence - A Smart Mesh NebuliserHCmed Innovations considers patient adherence and the role the company's mesh nebuliser places in monitoring it
-
2022Dec
07
Assessment of Fugitive Aerosol Emission During Actuation of a Breath-actuated Mesh NebuliserThe breath-actuated function of the mesh nebuliser, AdheResp, allowed for a substantial reduction in fugitive aerosol emission, demonstrating the benefits of breath actuation to reduce risk to fugitive aerosol exposure during nebulisation treatment.
-
2022Nov
25
A Roadmap for Drug-Nebuliser Combination Product DevelopmentHCmed Innovations summarizes the development process of drug-nebulizer combination products, describing a roadmap from early development to commercialization.
-
2022May
01
Assessing Delivered Dose of a Breath-Actuated Mesh Nebulizer: Breathing Simulator vs. NGI with Mixing Inlet Using Ipratropium BromideThis study aimed to evaluate two in-vitro test methods when assessing delivered dose for a breath-actuated mesh nebulizer, which only relies on a breathing simulator and the new method that incorporates a mixing inlet.
-
2022May
01
Aerosol Delivery Performance of Interferon Beta-1b with a Continuous Output Mode Mesh Nebulizer and a Breath-Actuated Mesh NebulizerIn this study, delivery of IFN-β-1b was assessed with two mesh nebulizers, a continuous output mode device and a breath-actuated nebulizer.
-
2022Apr
21
Aerosol Characterisation Techniques for Breath-Actuated NebulisersNew technologies and regulatory requirements are calling upon companies to utilise different methods as they try to create the best product possible.
-
2021Dec
08
Aerodynamic particle size distribution and delivered dose efficiency of a continuous-output mesh nebuliser and a novel breath-actuated device using terbutaline sulphateThe novel breath actuated mesh nebuliser AdheResp generated a high delivered dose and good fine particle fraction data compared to a similar continuous-output nebulizer.
-
2021Dec
01
An Overview to Drug-Nebulizer Combination Development with BiologicsBiologics are increasingly being investigated for delivery with inhalation therapy, which has initiated more in-depth discussions about the implications of formulation development and their pairing with inhaled devices for more efficient outcomes.
-
2021Nov
29
Delivering Suspensions with Mesh TechnologyIn this article, HCmed Innovations presents data supporting the efficient delivery of a suspension formulation with mesh nebulizers.